Treatment of Adults With Growth Hormone Deficiency

Launched by LG LIFE SCIENCES · Jan 15, 2008

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients (male and female) who have completed the Visit 8 of preceding main study (BPLG-005) and are willing to continue their participation in an extension study
• • If female, women of child-bearing potential who are using a reliable method of contraception and be willing to use it throughout the study. A negative urine pregnancy test at Visit 0 is required for females of child-bearing potential
• • Written informed consent of the patient
• Exclusion Criteria:
• • Evidence of active malignancy or growth of a previously stable tumor
• • Benign intracranial hypertension
• • Clinically significant respiratory, cardiac, hepatic, renal, neuromuscular disease
• • Non-compliance with medications, un-cooperativeness or drug abuse during the BPLG-005 study
• • Patients who are not able to comply with the study protocol for any reason